J.P. Morgan’s 2023 Outlook

Welcome back to our weekend Research Report and look inside all the macro-market driving forces for which we analyze...

Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is...

At first glance, U.S. equities seem to be riding a bullish wave. The S&P 500 is up more than...

No month-end equity selling but likely buying, what if ship breaks, Oil and CTAs Over the past few days,...

Two-Hundred Years of Market Concentration in the United States Dr. Bryan Taylor, Chief Economist, Global Financial Data Investors have...

The Paradox: The #1 concern for most investors/traders forces the diversification of a portfolio, which ultimately and perpetually underperforms...

Good weekend Finom Group members! This weekend is our “off reporting” weekend, but as always, we desire to offer...

Macro Strategy—Businesses have responded to unprecedented U.S. consumer-demand strength and rising capacity utilization rates by bringing real equipment investment...